Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma
Citation
Gargett, T, Abbas, M, Rolan, P et al 2018, 'Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma', Cancer Immunology, Immunotherapy, vol. 67, pp. 1461-1472pp.Year
2018ANU Authors
Field of Research
- Tumour Immunology